Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...

A 46-year-old Mount Pearl resident, who has lived with diabetes since 2003, will be the first to receive a prescription for a ...

Awiqli has been cleared for both types of diabetes in all its current markets except China, where it can be used for type 2 only. “We believe in the potential of once-weekly basal insulin icodec ...

Awiqli is currently approved in the EU, Canada, Australia, Japan and China for type I diabetes. The decline in the stock ...